Stock listing

CODX Stock Price, News, Filings & Events — Co-diagnostics, Inc.

Selected listing: CODX · BOATS · USD · US

This page tracks Co-diagnostics, Inc.'s CODX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CODX:BOATS. CODX:BOATS is the stock-level entry point for investors researching Co-diagnostics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Co-Diagnostics, Inc. is a public company traded under the ticker CODX in the American market. The company has a market capitalization of approximately $11 million. Co-Diagnostics focuses on developing molecular diagnostics for various diseases, leveraging its proprietary technology to enhance testing capabilities.

CODX:BOATSUSDUSUpdated August 28, 2026
Co-diagnostics, Inc. logo
Ticker
CODX:BOATS
Asset type
Stock
Market cap
$8.6M
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Co-diagnostics, Inc. CODX:BOATS stock context

This page tracks Co-diagnostics, Inc.'s CODX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CODX:BOATS. CODX:BOATS is the stock-level entry point for investors researching Co-diagnostics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Co-Diagnostics, Inc. is a public company traded under the ticker CODX in the American market. The company has a market capitalization of approximately $11 million. Co-Diagnostics focuses on developing molecular diagnostics for various diseases, leveraging its proprietary technology to enhance testing capabilities.

Latest news from Co-diagnostics, Inc.

All Co-diagnostics, Inc. news →

Co-diagnostics, Inc. earnings calls

Research Co-diagnostics, Inc.

Alternate listings